EUVIMEDSkopri EUVIMED
Crossref

Kidney Transplantation for Lithium Nephrotoxicity is Associated With Noninferior Graft and Patient Survival: A National Donor‐Stratified Registry Analysis

Hannah Cohen iD, Deric Toro, Dayanna Zuluaga iD, Giovanni Faddoul iD, Sidhartha D Ray iD, Gavin McAfee iD, Alex Chiodo Ortiz iD, Luke Gillenwalters iD, Nashitah Islam iD, Mary Ellen Dean, Syed Nazir iD, Naoru Koizumi iD and 2 more

Clinical Transplantation · 2026-05 · 40 (5)

DOI: 10.1111/ctr.70563 ↗

At a glance

Journal article in Clinical Transplantation, published online on 2026-05-15. Written by Hannah Cohen and 13 co-authors. Institution: Department of Primary Care, Touro College of Osteopathic Medicine, Middletown, New York, USA. Major MEDLINE topics: Kidney Transplantation, Graft Survival, Registries, Kidney Failure, Chronic. 30 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Introduction

To evaluate donor‐stratified graft and patient survival following kidney transplantation (KT) for lithium‐associated end‐stage kidney disease (ESKD).

Methods

This retrospective analysis utilized the Organ Procurement and Transplantation Network database. Adult KT recipients (January 1, 2015–December 30, 2024) with lithium‐associated nephrotoxicity as the primary listing diagnosis ( n = 840) were compared with those transplanted for other etiologies. Deceased‐donor (DDKT; n = 584) and living‐donor (LDKT; n = 256) cohorts were propensity matched 1:1 within donor type. Gompertz parametric survival models were selected after proportional hazards violation.

Results

Median follow‐up was 851 days (DDKT) and 1262 days (LDKT). Matched DDKT recipients with lithium‐associated ESKD had a lower prevalence of body mass index greater than 35 kg/m 2 (16.8% vs. 21.3%, p = 0.047), lower calculated panel reactive antibody (17.45 ± 30.58 vs. 27.85 ± 37.48, p < 0.001) and lower private insurance coverage (20.4% vs. 27.9%, p = 0.003). Lithium toxicity independently predicted reduced graft failure (HR, 0.668; 95% CI, 0.490–0.912; p = 0.011) and mortality (HR, 0.667; 95% CI, 0.483–0.921; p = 0.014). No other covariate retained independent significance in the adjusted model. Lithium‐associated ESKD did not predict graft failure or mortality among LDKT recipients.

Conclusion

KT for lithium‐associated ESKD was not associated with inferior outcomes. The favorable survival signal was confined to DDKT. It was more likely attributable to recipient‐level phenotypic differences and donor‐risk context than to any protective property of the underlying diagnosis. Posttransplant lithium dosing, compliance and rechallenge data are not captured in registry data and remain unmeasured.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationGraft SurvivalRegistriesKidney Failure, ChronicGraft RejectionTissue DonorsPostoperative ComplicationsLithiumHumansFemaleMaleRetrospective StudiesMiddle AgedPrognosisFollow-Up StudiesSurvival RateAdultRisk FactorsGlomerular Filtration RateKidney Function TestsTissue and Organ Procurement

Author keywords

graft survivalkidney transplantationlithium nephrotoxicitynational registry analysispatient survival

Substances

Lithium

Authors and institutions

  • Department of Primary Care, Touro College of Osteopathic Medicine, Middletown, New York, USA.
  • Department of Surgery, Garnet Health Medical Center, Middletown, New York, USA.
  • School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico, USA.
  • Department of Medicine, Albany Medical Center, Albany, New York, USA.
  • Department of Pharmaceutical and Biomedical Sciences, Touro University College of Pharmacy, New York, New York, USA.
  • Department of Surgery, Columbia University, New York, New York, USA.

ORCID profiles: Hannah Cohen, Dayanna Zuluaga, Giovanni Faddoul, Sidhartha D Ray, Gavin McAfee, Alex Chiodo Ortiz, Luke Gillenwalters, Nashitah Islam, Syed Nazir, Naoru Koizumi, Sohail Khan

Cite

APA

Cohen, H., Toro, D., Zuluaga, D., Faddoul, G., Ray, S. D., McAfee, G., Ortiz, A. C., Gillenwalters, L., Islam, N., Dean, M. E., Nazir, S., Koizumi, N., Ortiz, J., & Khan, S. (2026). Kidney Transplantation for Lithium Nephrotoxicity is Associated With Noninferior Graft and Patient Survival: A National Donor‐Stratified Registry Analysis. Clinical Transplantation, 40(5). https://doi.org/10.1111/ctr.70563

Vancouver

Cohen H, Toro D, Zuluaga D, Faddoul G, Ray SD, McAfee G, et al. Kidney Transplantation for Lithium Nephrotoxicity is Associated With Noninferior Graft and Patient Survival: A National Donor‐Stratified Registry Analysis. Clinical Transplantation. 2026;40(5). doi:10.1111/ctr.70563

BibTeX
@article{Cohen2026,
  author = {Cohen, Hannah and Toro, Deric and Zuluaga, Dayanna and Faddoul, Giovanni and Ray, Sidhartha D and McAfee, Gavin and Ortiz, Alex Chiodo and Gillenwalters, Luke and Islam, Nashitah and Dean, Mary Ellen and Nazir, Syed and Koizumi, Naoru and Ortiz, Jorge and Khan, Sohail},
  title = {Kidney Transplantation for Lithium Nephrotoxicity is Associated With Noninferior Graft and Patient Survival: A National Donor‐Stratified Registry Analysis},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {5},
  doi = {10.1111/ctr.70563}
}
Start for free →